Predicting the response to infliximab from trough serum levels.
Rutgeerts
Paul
P
Department of Medicine, Division of Gastroenterology, University of Leuven, Herestraat 49, 3052 Leuven, Belgium. paul.rutgeerts@uz.kuleuven.ac.be
Vermeire
Severine
S
Van Assche
Gert
G
D000911:Antibodies, Monoclonal / Q000097:blood* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods*; D005765:Gastrointestinal Agents / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab